VALENTINI, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 863
EU - Europa 314
AS - Asia 95
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 859
IE - Irlanda 94
SE - Svezia 88
CN - Cina 32
IT - Italia 32
PL - Polonia 32
RU - Federazione Russa 27
SG - Singapore 22
HK - Hong Kong 19
FI - Finlandia 16
TR - Turchia 15
DE - Germania 9
GB - Regno Unito 6
CA - Canada 4
AT - Austria 2
CH - Svizzera 2
EU - Europa 2
IN - India 2
JO - Giordania 2
NL - Olanda 2
VN - Vietnam 2
BY - Bielorussia 1
CZ - Repubblica Ceca 1
FR - Francia 1
KR - Corea 1
NZ - Nuova Zelanda 1
UA - Ucraina 1
Totale 1.275
Salva come PNG Salva come JPEG
Città #
Fairfield 155
Dublin 94
Chandler 77
Cambridge 70
Seattle 67
Ashburn 66
Houston 63
Woodbridge 62
Wilmington 59
Warsaw 32
Lawrence 21
Shanghai 21
Altamura 20
Buffalo 20
Princeton 20
Ann Arbor 15
Izmir 15
Boardman 14
Medford 14
Jacksonville 13
Singapore 12
Beijing 8
Boston 7
Florence 7
San Diego 5
Norwalk 4
Toronto 4
Moscow 3
Andover 2
Hamburg 2
Hong Kong 2
Morgan Hill 2
New York 2
Vienna 2
West Jordan 2
Ahmedabad 1
Antrim 1
Brno 1
Falls Church 1
Groningen 1
Helsinki 1
Hillsboro 1
Laurel 1
Livorno 1
Minsk 1
Naaldwijk 1
Newcastle upon Tyne 1
North Bergen 1
Nuremberg 1
Old Bridge 1
Redmond 1
Redwood City 1
Rome 1
Seoul 1
Shaoxing 1
Washington 1
Whangarei 1
Yuma 1
Zhengzhou 1
Totale 1.006
Salva come PNG Salva come JPEG
Nome #
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 110
Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group 81
Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosis. 78
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study 78
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. 76
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). 73
Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. 70
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. 70
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. 69
Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis 64
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects. 64
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. 61
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. 59
Rheumatology and dermatology: sister specialities in Italy and Malta. 59
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. 59
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 47
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs]. 42
Disease-specific quality indicators, guidelines and outcome measures in scleroderma. 39
Colchicine treatment of Behçet's disease in children. 32
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. 30
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 20
Totale 1.281
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020270 0 10 4 17 25 40 39 41 47 14 28 5
2020/2021160 28 11 14 8 3 14 2 19 11 31 14 5
2021/2022137 4 12 14 1 7 4 3 7 14 3 26 42
2022/2023357 35 58 34 23 24 66 51 10 35 2 16 3
2023/2024120 7 15 21 7 9 29 4 9 2 5 1 11
2024/202547 30 17 0 0 0 0 0 0 0 0 0 0
Totale 1.281